GLP-1, Weight loss

Exclusive: Weight-loss drugs didn't curb health costs within two years, data show
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters. The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 drugs was $18,
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
The future of the weight loss market might not revolve around GLP-1 drugs.
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates and addressing health inequities. Current drug uptake levels prevent far fewer deaths.
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
Data shows weight-loss drugs didn’t curb health costs within two years: Report
Prime Therapeutics reviewed pharmacy and medical claims data for 3,046 people with commercial health plans that cover GLP-1 drugs.
Ozempic isn't the only answer: Here's how to naturally boost GLP-1 levels for healthy weight loss
Forget Ozempic drug that Karan Johar was accused of taking for dramatic weight loss. Here are 8 expert ways to naturally supercharge your GLP-1.
‘Miracle’ GLP-1 agonist weight-loss drugs help US woman shed 18kg, stop her prediabetes
Semaglutide and tirzepatide helped Texas woman Kathryn Dean lose 18kg and keep the weight off, and she is no longer diagnosed as prediabetic For 52-year-old American property agent and aesthetician Kathryn Dean,
San Francisco Examiner6h
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
THURSDAY, Oct. 24, 2024 (HealthDay News) -- Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and ...
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
A look at the effects of weight-loss medications on menopause
As more women speak openly about menopause and the changes it brings, some doctors say GLP-1 medications like Ozempic and ...
Healthline6d
Ozempic Microdosing Is Gaining Popularity. Does It Work for Weight Loss?
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...
fingerlakes12d
Insurance companies to raise BMI threshold for weight loss drug coverage
Starting next year, insurance companies, including Highmark, will introduce stricter requirements for covering GLP-1 weight ...
GlobalData on MSN1d
MangoRx hits back at Eli Lilly’s weight loss drug copycat claims
MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this ...